Lataa...
The Antitumor Activity of Sodium Selenite Alone and in Combination with Gemcitabine in Pancreatic Cancer: An In Vitro and In Vivo Study
SIMPLE SUMMARY: The treatment of advanced pancreatic cancer represents a major challenge because of its chemoresistance and low survival rate. The aim of this research is to test a new antitumor agent (sodium selenite) in pancreatic cancer, both in vitro and in vivo, focusing on the molecular mechan...
Tallennettuna:
| Julkaisussa: | Cancers (Basel) |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8268835/ https://ncbi.nlm.nih.gov/pubmed/34201986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13133169 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|